2009 annual financial data
Eloxx Pharmaceuticals 2009 Operating margin
Direct answer
Operating margin was -1,558.07%.
Operating income was -4,284,701 USD and net income was -5,726,869 USD.
Operating cash flow was -3,962,680 USD.
Get free Eloxx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 275,000 USD
- Operating income
- -4,284,701 USD
- Net income
- -5,726,869 USD
- Operating cash flow
- -3,962,680 USD